特邀演讲科学家及演讲主题
l Harvey Alter, M.D (Bethesda, USA)： HCV natural history
l Shengli Bi, M.D (Beijing China): Viral Hepatitis in China
l Maria Buti, M.D (Barcelona, Spain)： HBV treatment
l PeiJer Chen, M.D &Ph.D (Chinese Taipei): Molecular biology of HDV
l Raphael Esteban, M.D (Barcelona, Spain)： Treatment of HCV
l Michael Favorov, M.D, Ph.D, D.Sc (Atlanta, USA)：HEV Epidemiology
l Stephen M. Feinstone, M.D. (Bethesda, USA)： HAV vaccine update
l John L. Gerin, Ph.D. (Washington, DC, USA)： HBV and hepatoma
l Jungsuh Park Kim, Ph.D. (Seoul, Korea)： HEV discovery
l Lanjuan Li, M.D. (Hangzhou, China): Fulminate hepatitis
l Xiaofeng Liang, Ph.D. (Beijing China ): Vaccine strategy in China
l Jiangsen Mao, Ph.D. (Hangzhou, China): HAV in China
l Masashi Mizokami, M.D. & Ph.D. (Nagoya, Japan)：HBV evolution
l Mun-Hon Ng, Ph.D. (Xiamen, China)： HEV vaccine
l Mario Rizzetto, M.D. (Turino, Italy)： HDV infection
l Bill Rutter,Ph.D. (San Francisco, USA)： HCV discovery
l Youchun Wang, Ph.D. ( Beijing China): HEV type 4
l Yumei Wen, M.D (Shanghai, China)： HBV virology and vaccine
当前位置：首页 >>